|1.||Kaur, Jatinder: 3 articles (01/2013 - 03/2009)|
|2.||Mayur, Y C: 3 articles (07/2011 - 09/2008)|
|3.||Jiang, Yuyang: 2 articles (06/2015 - 01/2013)|
|4.||Li, Shangfu: 2 articles (06/2015 - 01/2013)|
|5.||Gao, Chunmei: 2 articles (06/2015 - 01/2013)|
|6.||Liu, Feng: 2 articles (06/2015 - 01/2013)|
|7.||Rane, Rajesh A: 2 articles (01/2015 - 01/2015)|
|8.||Mahajan, Anand A: 2 articles (01/2015 - 01/2015)|
|9.||García, Cybele C: 2 articles (01/2015 - 01/2008)|
|10.||Damonte, Elsa B: 2 articles (01/2015 - 01/2008)|
07/01/2014 - "The goal of this study was to assess efficacy of acridone acetic acid, sodium salt (Na-AAA), an immunomodulating compound with favorable safety profile, in stabilizing active vitiligo, and to reveal prognostic factors of treatment outcome. "
07/01/2014 - "In conclusion, acridone acetic acid, sodium salt, emerges as an efficient option for stopping vitiligo progression. "
07/01/2014 - "Acridone acetic acid, sodium salt, as an agent to stop vitiligo progression: a pilot study."
07/17/2011 - "Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies."
01/01/2015 - "The diverse biological activity of acridone and its prospective in reversal of multi-drug resistance has attracted attention of medicinal chemists to explore this scaffold especially to treat multi-drug resistance in cancer. "
07/17/2011 - "A series of novel N(10)-substituted acridone derivatives bearing alkyl side-chain with tertiary amine groups at the terminal position were evaluated for their in vitro cytotoxic effects against drug sensitive and resistant cancer cell lines. "
05/01/2009 - "This article envisages the various drugs being developed for treating MDR in cancer cells and especially the acridone derivatives which are being developed by the author."
08/01/2001 - "The cytotoxicity of several acridone alkaloid isolates (3-8) was evaluated against a small tumor cell panel."
01/01/2013 - "Herein, we report the use of an UPLC/Q-TOF MS metabolomic approach to study the effects of three compounds with structures optimized step-by-step, 9(10H)-acridone (A), 10-(3,5-dimethoxy)benzyl-9(10H)-acridone (I), and 8a, on CCRF-CEM leukemia cells and to shed new light on the probable antitumor mechanism of 8a. "
09/15/2015 - "Acridone alkaloid 5 induced apoptosis in CCRF-CEM leukemia cells, mediated by increased ROS production. "
01/01/2013 - "Taken together our results suggest that the acridone derivative 8a induces oxidative stress-mediated apoptosis in CCRF-CEM leukemia cells. "
01/01/2013 - "Acridone derivative 8a induces oxidative stress-mediated apoptosis in CCRF-CEM leukemia cells: application of metabolomics in mechanistic studies of antitumor agents."
06/01/2015 - "The biologic activity of the acridone compounds against leukemia CCRF-CEM cells demonstrated that some of the compounds displayed good antiproliferative activity, among which compound 6a containing dimethylamine substituents at the terminal C2 and C7 positions exhibited the highest cytotoxicity with IC50 at 0.3μM. "
04/20/2006 - "In this study we report the design, synthesis, and activity against bovine viral diarrhea virus (BVDV) of a novel series of acridone derivatives. "
05/28/2009 - "We report the synthesis and structure-activity relationship (SAR) of a large series of acridones and acridone-fragment derivatives designed on the basis of the selective antihepatitis C virus (HCV) activity shown by acridone 2, previously studied as a potential antibovine viral diarrhea virus (BVDV) compound. "
01/01/2014 - "Cytotoxic activities for the isolated acridone alkaloids were evaluated against two prostate cancer cell lines PC-3M and Lymph Node Carcinoma of Prostate (LNCaP), and their antimalarial activities were tested against two different strains of the parasite Plasmodium falciparum 3D7, and Dd2. "
08/01/2000 - "Using polarized cell lines stably expressing human MDR1, MRP1 or MRP2cDNA, and 2008 ovarian carcinoma cells stably expressing MRP1 cDNA, we have investigated in this study the specificity of the reversal agents V-104 (a pipecolinate derivative), GF120918 (an acridone carboxamide derivative also known as GG918), and Pluronic L61 (a (poly)oxypropethylene and (poly)oxypropylene block copolymer). "
|1.||Acetic Acid (Vinegar)
|3.||GF 120918 (Elacridar)
|4.||Complementary DNA (cDNA)
|5.||Antineoplastic Agents (Antineoplastics)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)